{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-072068","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.746268+00:00","generated_at":"2026-05-17T20:48:51.675523+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Hoth Therapeutics shareholders approve director re-election and plan amendment at 2025 annual meeting","bullets":["All five director nominees (Knie, Sarnoff, Linsley, Pavell, Camarra) re-elected with strong support.","Ratification of Withum as auditor for FY2025 approved: 4,559,052 for, 247,728 against.","Amendment to 2022 Plan to increase share reserve from 1,091,317 to 3,091,317 shares approved.","Advisory vote on 2024 executive compensation approved: 1,098,368 for, 265,965 against.","Shareholders selected one-year frequency for future advisory votes on executive pay."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-072068","json":"https://secwatch.observer/filing/0001213900-25-072068.json","markdown":"https://secwatch.observer/filing/0001213900-25-072068.md","text":"https://secwatch.observer/filing/0001213900-25-072068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390025072068/0001213900-25-072068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390025072068/ea0251896-8k_hoth.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:48:51.675523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}